These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7677997)
1. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997 [TBL] [Abstract][Full Text] [Related]
2. Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor. Olsen DB; Carroll SS; Culberson JC; Shafer JA; Kuo LC Nucleic Acids Res; 1994 Apr; 22(8):1437-43. PubMed ID: 7514786 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate. Reardon JE; Miller WH J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one. Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173 [TBL] [Abstract][Full Text] [Related]
5. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693 [TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer. Jaju M; Beard WA; Wilson SH J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs. Carroll SS; Stahlhut M; Geib J; Olsen DB J Biol Chem; 1994 Dec; 269(51):32351-7. PubMed ID: 7528214 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T). Balzarini J; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; Bathurst IC; Barr PJ; De Clercq E J Biol Chem; 1992 Jun; 267(17):11831-8. PubMed ID: 1376314 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues. Hoffman JM; Smith AM; Rooney CS; Fisher TE; Wai JS; Thomas CM; Bamberger DL; Barnes JL; Williams TM; Jones JH J Med Chem; 1993 Apr; 36(8):953-66. PubMed ID: 7683054 [TBL] [Abstract][Full Text] [Related]
10. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800 [TBL] [Abstract][Full Text] [Related]
11. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors. Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595 [TBL] [Abstract][Full Text] [Related]
12. Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors. Condra JH; Emini EA; Gotlib L; Graham DJ; Schlabach AJ; Wolfgang JA; Colonno RJ; Sardana VV Antimicrob Agents Chemother; 1992 Jul; 36(7):1441-6. PubMed ID: 1380789 [TBL] [Abstract][Full Text] [Related]
13. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. Tan GT; Kinghorn AD; Hughes SH; Pezzuto JM J Biol Chem; 1991 Dec; 266(35):23529-36. PubMed ID: 1721050 [TBL] [Abstract][Full Text] [Related]
14. Template. Phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase. Maury G; el Alaoui A; Morvan F; Müller B; Imbach JL; Goody RS Biochem Biophys Res Commun; 1992 Aug; 186(3):1249-56. PubMed ID: 1380799 [TBL] [Abstract][Full Text] [Related]
15. DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate. Orr DC; Figueiredo HT; Mo CL; Penn CR; Cameron JM J Biol Chem; 1992 Feb; 267(6):4177-82. PubMed ID: 1371285 [TBL] [Abstract][Full Text] [Related]
16. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors. Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996 [TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus reverse transcriptase. Effect of primer length on template-primer binding. Reardon JE; Furfine ES; Cheng N J Biol Chem; 1991 Jul; 266(21):14128-34. PubMed ID: 1713216 [TBL] [Abstract][Full Text] [Related]
18. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944 [TBL] [Abstract][Full Text] [Related]